Trials / Completed
CompletedNCT02536664
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants
RIM - Rituximab in Maintenance
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 505 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is a non-interventional study with a duration of approximately 24 months per participant to investigate the therapeutic efficiency, safety and treatment regimens of Rituximab maintenance therapy in daily routine in participants with previously untreated, relapsed or refractory cluster of differentiation 20 (CD20)-positive follicular lymphoma (FL) in clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rituximab |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2015-09-01
- Last updated
- 2023-04-18
- Results posted
- 2015-11-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02536664. Inclusion in this directory is not an endorsement.